Landmark study shows Libre technology helps people with Type 2 diabetes on basal insulin improve glucose management (opens in new tab)

U.K. FreeDM2 randomized controlled trial: At four months, people using Libre technology had a 0.6% greater reduction in HbA1c and 2.5 more hours a day in the healthy range vs. fingersticks 1,2...